Evidence map›Paper›PMID 31665242›Full record

ArticleBrain : a journal of neurology2019

Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain.

Juliette Van Steenwinckel, Anne-Laure Schang, Michelle L Krishnan, Vincent Degos, Andrée Delahaye-Duriez, Cindy Bokobza, Zsolt Csaba, Franck Verdonk, Amélie Montané, Stéphanie Sigaut and 22 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Juliette Van SteenwinckelUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Anne-Laure SchangUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Michelle L KrishnanCentre for the Developing Brain, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, SE1 7EH, UK.
Vincent DegosUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Andrée Delahaye-DuriezUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Cindy BokobzaUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Zsolt CsabaUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Franck VerdonkInfection and Epidemiology Department, Human Histopathology and Animal Models Unit, Institut Pasteur, F-75015 Paris, France.
Amélie MontanéUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Stéphanie SigautUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Olivier HennebertUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Sophie LebonUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Leslie SchwendimannUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Tifenn Le CharpentierUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Rahma Hassan-AbdiUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Gareth BallCentre for the Developing Brain, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, SE1 7EH, UK.
Paul AljabarCentre for the Developing Brain, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, SE1 7EH, UK.
Alka SaxenaGenomics Core Facility, NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK.
Rebecca K HollowayMRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, EH16 4TJ, UK.
Walter BirchmeierCancer Research Program, Max Delbrueck Center for Molecular Medicine in the Helmholtz Society, Berlin-Buch, Germany.
Olivier BaudUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
David RowitchDepartment of Paediatrics, University of Cambridge, Cambridge, CB2 0QQ, UK.
Veronique MironMRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, EH16 4TJ, UK.
Fabrice ChretienUFR de Santé, Médecine et Biologie Humaine, Université Paris 13, Sorbonne Paris Cité, F-93000 Bobigny, France.
Claire LeconteEA4475 - Pharmacologie de la Circulation Cérébrale, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, F-75006 Paris, France.
Valérie C BessonEA4475 - Pharmacologie de la Circulation Cérébrale, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, F-75006 Paris, France.
Enrico G PetrettoDuke-NUS Medical School, 8 College Road 169857, Singapore.
A David EdwardsCentre for the Developing Brain, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, SE1 7EH, UK.
Henrik HagbergCentre for the Developing Brain, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, SE1 7EH, UK.
Nadia Soussi-YanicostasUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Bobbi FleissUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.
Pierre GressensUniversité de Paris, NeuroDiderot, Inserm, F-75019 Paris, France.

Funding

Department of Health RP-PG-0707-10154Medical Research Council MC_PC_12009Medical Research Council MC_U120097112Medical Research Council MR/K006355/1Medical Research Council MR/M020827/1Medical Research Council MR/N022556/1Wellcome Trust
6 · The paper itself

Abstract

Microglia of the developing brain have unique functional properties but how their activation states are regulated is poorly understood. Inflammatory activation of microglia in the still-developing brain of preterm-born infants is associated with permanent neurological sequelae in 9 million infants every year. Investigating the regulators of microglial activation in the developing brain across models of neuroinflammation-mediated injury (mouse, zebrafish) and primary human and mouse microglia we found using analysis of genes and proteins that a reduction in Wnt/β-catenin signalling is necessary and sufficient to drive a microglial phenotype causing hypomyelination. We validated in a cohort of preterm-born infants that genomic variation in the Wnt pathway is associated with the levels of connectivity found in their brains. Using a Wnt agonist delivered by a blood-brain barrier penetrant microglia-specific targeting nanocarrier we prevented in our animal model the pro-inflammatory microglial activation, white matter injury and behavioural deficits. Collectively, these data validate that the Wnt pathway regulates microglial activation, is critical in the evolution of an important form of human brain injury and is a viable therapeutic target.

Indexed as

AnimalsAnimals, Genetically ModifiedBlood-Brain BarrierBrainCells, CulturedComputational BiologyHumansInflammationMiceMicrogliaWnt Signaling PathwayZebrafish3DNAinnate immunityneonatal encephalopathyneuroinflammationneuroprotection

Identifiers

PMID31665242
PMCPMC6906599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.